

Dean McGee Eye Institute, Together with OU Health, Offering New Gene Therapy Treatment for an Inherited Retinal Disease
News Release Dean McGee Eye Institute, Together with OU Health, Offering New Gene Therapy Treatment for an Inherited Retinal Disease The Dean McGee Eye Institute (DMEI) has been named one of the newest sites for administering Spark Therapeutics’ LUXTURNA® (voretigne...